Banque Cantonale Vaudoise Acquires New Shares in iShares U.S. Pharmaceuticals ETF $IHE

Banque Cantonale Vaudoise acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 24,500 shares of the company’s stock, valued at approximately $2,077,000.

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Assetmark Inc. boosted its position in iShares U.S. Pharmaceuticals ETF by 203.9% in the fourth quarter. Assetmark Inc. now owns 465 shares of the company’s stock valued at $39,000 after buying an additional 312 shares during the last quarter. Ameriflex Group Inc. boosted its position in iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Ameriflex Group Inc. now owns 582 shares of the company’s stock valued at $42,000 after buying an additional 291 shares during the last quarter. National Bank of Canada FI boosted its position in iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock valued at $42,000 after buying an additional 175 shares during the last quarter. NBC Securities Inc. boosted its position in iShares U.S. Pharmaceuticals ETF by 46.5% in the fourth quarter. NBC Securities Inc. now owns 630 shares of the company’s stock valued at $53,000 after buying an additional 200 shares during the last quarter. Finally, Rothschild Investment LLC boosted its position in iShares U.S. Pharmaceuticals ETF by 116.9% in the third quarter. Rothschild Investment LLC now owns 846 shares of the company’s stock valued at $61,000 after buying an additional 456 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Up 1.3%

Shares of NYSEARCA IHE opened at $90.44 on Friday. The business’s 50 day moving average price is $87.01 and its 200 day moving average price is $86.12. The firm has a market cap of $976.75 million, a P/E ratio of 17.75 and a beta of 0.49. iShares U.S. Pharmaceuticals ETF has a 52 week low of $63.03 and a 52 week high of $92.29.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.